Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$50.45 - $72.82 $46,313 - $66,848
-918 Reduced 9.34%
8,910 $468,000
Q1 2023

May 15, 2023

SELL
$51.25 - $79.34 $60,065 - $92,986
-1,172 Reduced 10.65%
9,828 $629,000
Q4 2022

Feb 14, 2023

SELL
$46.82 - $76.2 $43,027 - $70,027
-919 Reduced 7.71%
11,000 $534,000
Q3 2022

Nov 14, 2022

SELL
$70.55 - $111.58 $48,044 - $75,985
-681 Reduced 5.4%
11,919 $841,000
Q2 2022

Aug 15, 2022

BUY
$50.24 - $80.48 $130,624 - $209,248
2,600 Added 26.0%
12,600 $894,000
Q1 2022

May 16, 2022

BUY
$57.98 - $93.5 $114,568 - $184,756
1,976 Added 24.63%
10,000 $799,000
Q4 2021

Feb 14, 2022

BUY
$88.02 - $127.79 $398,202 - $578,121
4,524 Added 129.26%
8,024 $733,000
Q3 2021

Nov 15, 2021

SELL
$122.75 - $162.68 $209,779 - $278,020
-1,709 Reduced 32.81%
3,500 $450,000
Q2 2021

Aug 16, 2021

BUY
$105.76 - $154.96 $19,565 - $28,667
185 Added 3.68%
5,209 $794,000
Q1 2021

May 14, 2021

BUY
$78.5 - $126.48 $28,417 - $45,785
362 Added 7.76%
5,024 $530,000
Q4 2020

Feb 16, 2021

SELL
$55.93 - $82.78 $130,764 - $193,539
-2,338 Reduced 33.4%
4,662 $369,000
Q3 2020

Nov 16, 2020

SELL
$45.65 - $61.81 $1.05 Million - $1.43 Million
-23,063 Reduced 76.72%
7,000 $396,000
Q2 2020

Aug 14, 2020

SELL
$29.15 - $61.54 $24,165 - $51,016
-829 Reduced 2.68%
30,063 $1.85 Million
Q1 2020

May 15, 2020

BUY
$25.01 - $42.4 $272,408 - $461,820
10,892 Added 54.46%
30,892 $997,000
Q3 2019

Nov 14, 2019

SELL
$25.78 - $34.8 $193,350 - $260,999
-7,500 Reduced 27.27%
20,000 $516,000
Q2 2019

Aug 14, 2019

BUY
$23.08 - $37.01 $634,700 - $1.02 Million
27,500 New
27,500 $808,000
Q4 2017

Feb 14, 2018

SELL
$12.45 - $17.4 $249,000 - $348,000
-20,000 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$10.25 - $12.8 $205,000 - $256,000
20,000
20,000 $249,000

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.15B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.